Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-04-08, Stock:LLY, The news for the past five days is as follows:
2019-04-01: NEWS1: 3 Big Pharma Stocks to Add to Your Portfolio This April.NEWS2: 3 Big Pharma Stocks to Add to Your Portfolio This April.NEWS3: BMO’s Got A Point About Teva Stock, But Are Investors Willing To Listen?.NEWS4: BMO’s Got A Point About Teva Stock, But Are Investors Willing To Listen?.NEWS5: 3 Big Pharma Stocks to Add to Your Portfolio This April.NEWS6: BMO’s Got A Point About Teva Stock, But Are Investors Willing To Listen?.NEWS7: Arteaus Therapeutics Sells Emgality Royalty to Royalty Pharma for $260 Million.
2019-04-02: NEWS1: Teva's Anti-CGRP Injection Ajovy Gets Approval in Europe.NEWS2: Teva's Anti-CGRP Injection Ajovy Gets Approval in Europe.NEWS3: Merck's Keytruda Gets Nod for First-Line Lung Cancer in China.NEWS4: Merck's Keytruda Gets Nod for First-Line Lung Cancer in China.NEWS5: AVEO Reports Positive Results on Leukemia Drug, Shares Up.NEWS6: AVEO Reports Positive Results on Leukemia Drug, Shares Up.NEWS7: AVEO Reports Positive Results on Leukemia Drug, Shares Up.NEWS8: Merck's Keytruda Gets Nod for First-Line Lung Cancer in China.NEWS9: Teva's Anti-CGRP Injection Ajovy Gets Approval in Europe.
2019-04-03: NEWS1: Alector (ALEC) Initiates Phase I Alzheimer's Study on AL003.NEWS2: Alector (ALEC) Initiates Phase I Alzheimer's Study on AL003.NEWS3: Vanguard Value ETF Experiences Big Inflow.NEWS4: Vanguard Value ETF Experiences Big Inflow.NEWS5: Alector (ALEC) Initiates Phase I Alzheimer's Study on AL003.NEWS6: Cigna launches program to cap out-of-pocket insulin costs at $25/month.
2019-04-04: nan
2019-04-05: NEWS1: Novartis & Amgen in Legal Dispute Over Migraine Drug Aimovig.NEWS2: Novartis & Amgen in Legal Dispute Over Migraine Drug Aimovig.NEWS3: Dow 30 Stock Roundup: WBA Q2 Earnings Disappoint, PFE Lung Cancer Drug Gets EU Approval.NEWS4: Dow 30 Stock Roundup: WBA Q2 Earnings Disappoint, PFE Lung Cancer Drug Gets EU Approval.NEWS5: Novartis & Amgen in Legal Dispute Over Migraine Drug Aimovig.NEWS6: Health Day Checkup of Medical ETFs: 5 Top Picks.NEWS7: Health Day Checkup of Medical ETFs: 5 Top Picks.NEWS8: Dow 30 Stock Roundup: WBA Q2 Earnings Disappoint, PFE Lung Cancer Drug Gets EU Approval.NEWS9: Health Day Checkup of Medical ETFs: 5 Top Picks.

Answer: Rise